Kalgera reaches £3.1m valuation following £144.5k funding round

Applying neuroscience and machine learning to banking security, Kalgera Limited has raised an estimated £144.5k in new funding. The King's Cross based company reached an estimated post-money valuation of £3.1m following the investment.

Founded in 2017 by a UCL Cognitive Neurology researcher, Kalgera develops an AI-driven financial intelligence platform. The software utilizes neuroscience to identify financial vulnerability and prevent fraud before it occurs. The company targets financial institutions, providing tools to proactively support at-risk customers, with a specific focus on older populations and their caregivers.

The current valuation of £3.1m marks an increase from the £2.9m valuation achieved in April 2025, when the company raised £31.9k. Kalgera has maintained a consistent schedule of capital injections over the last several years. In 2024, the firm completed three separate rounds in May, June, and July, raising a combined £95.2k at a steady valuation of £2.7m. (The current round was allotted in March and documented in filings during May).

Earlier funding activity includes a £250k round in April 2023 at a £2.6m valuation and a £200k round in April 2022 at a £2.3m valuation. The company's largest single raise to date was a £352k round in July 2021, which valued the business at £2m. Since its first recorded raise of £25.4k in April 2019, the company's valuation has grown from £1.3m to its current £3.1m.

Kalgera currently operates with a team of three employees. The platform integrates data science and health technology to safeguard the financial lives of vulnerable individuals by monitoring bank processes for signs of cognitive decline or exploitation.